Prior Authorization Is Entering Its Proof Stage for RCM Teams
TL;DR: The story is no longer whether prior authorization reform sounds good. The real question is whether revenue cycle teams can see measurable relief in the data.
Word Count: 463
Estimated Reading Time: ~3 minutes
Prior authorization has been a long-running source of friction, but the conversation is changing. CMS is now pushing the market from policy language into implementation. Its current electronic prior authorization materials tie the June 2025 industry pledge to concrete next steps: standardized FHIR-based workflows, reduced prior authorization volume, stronger denial transparency, and broader use of real-time approvals by 2027. On paper, that is real movement.
The problem is that provider trust has not caught up. The American Medical Association reported on May 13 that only 33% of physicians believe the latest insurer pledge will make a meaningful difference. The same survey found that 95% say prior authorization delays necessary care, 32% say requests are often or always denied, and physicians and staff spend an average of 13 hours a week on prior authorization work. That gap between announced reform and experienced burden is why this has become an RCM operating story instead of just a policy update.
For revenue cycle leaders, the next phase is about proof. If simplification is real, teams should start seeing cleaner authorization workflows, fewer requests for additional documentation, clearer denial reasons, and less time lost to portals, phone calls, and fax follow-up. If those signals do not improve, then the industry may be modernizing its language faster than it is modernizing actual operations.
There are signs that payers understand they now need to show tangible progress. UnitedHealthcare said in late April that more than half of its prior authorization volume will be part of a standardized electronic submission process, with more than 70% expected by year-end. The company also pointed to additional reductions in prior authorization requirements, real-time status tracking, and faster decisions. That matters because RCM teams do not need another abstract commitment. They need fewer exception queues and less rework.
This is where the proof stage begins. Teams should baseline authorization turnaround time by payer, auth-related denial rates, rates of manual intervention, and the share of requests that trigger additional documentation or peer-to-peer review. They should also look for downstream effects in delayed procedures, avoidable reschedules, and A/R aging tied to authorization failure points. Those are the signals that can separate real operational improvement from headline management.
A capable revenue cycle team should treat 2026 as a measurement year. Build payer-level scorecards now. Map which service lines generate the most avoidable rework. Track whether denial reasons are becoming more specific and whether electronic status data is actually usable inside existing workflows. Prior authorization reform will only matter at the operator level if it reduces touches, accelerates decisions, and lowers preventable denials. The proof will show up in the work before it shows up in the press release.
This is the kind of issue RevOps customers can detect in operational data before it becomes a larger exposure.